{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:14:14Z","timestamp":1790957654823,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T00:00:00Z","timestamp":1603065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Foundation of the State of Rio Grande do Sul (FAPERGS).","award":["FAPERGS - 02\/2017 PqG"],"award-info":[{"award-number":["FAPERGS - 02\/2017 PqG"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Braz J Microbiol"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1007\/s42770-020-00384-0","type":"journal-article","created":{"date-parts":[[2020,10,19]],"date-time":"2020-10-19T12:06:03Z","timestamp":1603109163000},"page":"1819-1823","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vancomycin MIC and agr dysfunction in invasive MRSA infections in southern Brazil"],"prefix":"10.1007","volume":"51","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5597-0790","authenticated-orcid":false,"given":"Adriana Medianeira","family":"Rossato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7117-7714","authenticated-orcid":false,"given":"Muriel","family":"Primon-Barros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8358-1183","authenticated-orcid":false,"given":"C\u00edcero Arm\u00eddio Gomes","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8539-7833","authenticated-orcid":false,"given":"Pedro Alves","family":"d\u2019Azevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,19]]},"reference":[{"key":"384_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2018.33","volume":"4","author":"AS Lee","year":"2018","unstructured":"Lee AS, de Lencastre H, Garau J, Kluytmans J, Malhotra-Kumar S, Peschel A, Harbarth S (2018) Methicillin-resistant Staphylococcus aureus. Nat Rev Dis Primers 4:1\u201323. https:\/\/doi.org\/10.1038\/nrdp.2018.33","journal-title":"Nat Rev Dis Primers"},{"key":"384_CR2","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9849-4","volume-title":"Methicillin-resistant Staphylococcus aureus (MRSA)","author":"Y Ji","year":"2020","unstructured":"Ji Y (2020) Methicillin-resistant Staphylococcus aureus (MRSA), 3rd edn. Humana Press, Saint Paul","edition":"3"},{"key":"384_CR3","volume-title":"Performance standards for antimicrobial susceptibility testing","author":"Clinical and Laboratory Standards Institute (CLSI)","year":"2020","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2020) Performance standards for antimicrobial susceptibility testing, 3rd edn. Clinical and Laboratory Standards Institute, Wayne","edition":"3"},{"key":"384_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-017-2609-0","volume":"17","author":"DM Martirosov","year":"2017","unstructured":"Martirosov DM, Bidell MR, Pai MP et al (2017) Relationship between day 1 and day 2 vancomycin area under the curve values and emergence of heterogeneous vancomycin-intermediate Staphylococcus aureus (hVISA) by Etest\u00ae macromethod among patients with MRSA bloodstream infections: a pilot study. BMC Inf Dis 17:1\u20137. https:\/\/doi.org\/10.1186\/s12879-017-2609-0","journal-title":"BMC Inf Dis"},{"key":"384_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fmicb.2018.00055","volume":"9","author":"L Tan","year":"2018","unstructured":"Tan L, Li SR, Jiang B, Hu XM, Li S (2018) Therapeutic targeting of the Staphylococcus aureus accessory gene regulator (agr) system. Front in Microbiol 9:1\u201311. https:\/\/doi.org\/10.3389\/fmicb.2018.00055","journal-title":"Front in Microbiol"},{"key":"384_CR6","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1146\/annurev-micro-102215-095708","volume":"70","author":"D Bronesky","year":"2016","unstructured":"Bronesky D, Wu Z, Marzi S et al (2016) Staphylococcus aureus RNAIII and its regulon link quorum sensing, stress responses, metabolic adaptation, and regulation of virulence gene expression. Ann Rev Microbiol 70:29\u2013316. https:\/\/doi.org\/10.1146\/annurev-micro-102215-095708","journal-title":"Ann Rev Microbiol"},{"key":"384_CR7","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/cbic.200700023","volume":"8","author":"EA George","year":"2007","unstructured":"George EA, Muir TW (2007) Molecular mechanisms of agr quorum sensing in virulent staphylococci. ChemBioChem 8:847\u2013855. https:\/\/doi.org\/10.1002\/cbic.200700023","journal-title":"ChemBioChem"},{"key":"384_CR8","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1515\/med-2018-0071","volume":"13","author":"J Xu","year":"2018","unstructured":"Xu J, Pang L, Ma XX, Hu J, Tian Y, Yang YL, Sun DD (2018) Phenotypic and molecular characterisation of Staphylococcus aureus with reduced vancomycin susceptibility derivated in vitro. Open Medicine 13:475\u2013486. https:\/\/doi.org\/10.1515\/med-2018-0071","journal-title":"Open Medicine"},{"key":"384_CR9","doi-asserted-by":"publisher","first-page":"1473","DOI":"10.1007\/s10096-017-2956-1","volume":"36","author":"T Kim","year":"2017","unstructured":"Kim T, Kim ES, Park SY, Sung H, Kim MN, Kim SH, Lee SO, Choi SH, Jeong JY, Woo JH, Chong YP, Kim YS (2017) Phenotypic changes of methicillin-resistant Staphylococcus aureus during vancomycin therapy for persistent bacteraemia and related clinical outcome. Eur J Clin Microbiol 36:1473\u20131481. https:\/\/doi.org\/10.1007\/s10096-017-2956-1","journal-title":"Eur J Clin Microbiol"},{"key":"384_CR10","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","volume":"54","author":"SJ van Hal","year":"2012","unstructured":"van Hal SJ, Lodise TP, Paterson DL (2012) The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis. Clin Infect Dis 54:755\u2013771. https:\/\/doi.org\/10.1093\/cid\/cir935","journal-title":"Clin Infect Dis"},{"key":"384_CR11","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.mimet.2014.08.024","volume":"107","author":"R Lawung","year":"2014","unstructured":"Lawung R, Chuong L v, Cherdtrakulkiat R et al (2014) Revelation of staphylococcal cassette chromosome mec types in methicillin-resistant Staphylococcus aureus isolates from Thailand and Vietnam. J Microb Meth 107:8\u201312. https:\/\/doi.org\/10.1016\/j.mimet.2014.08.024","journal-title":"J Microb Meth"},{"key":"384_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.17058\/reci.v8i4.11393","volume":"8","author":"AM Rossato","year":"2018","unstructured":"Rossato AM, Reiter KC, Soares RO et al (2018) Molecular characteristics of vancomycin-susceptible Staphylococcus aureus could help to predict treatment failure due to reduced vancomycin susceptibility. Rev Epid Cont de Infec 8:422\u2013427. https:\/\/doi.org\/10.17058\/reci.v8i4.11393","journal-title":"Rev Epid Cont de Infec"},{"key":"384_CR13","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1099\/jmm.0.023465-0","volume":"60","author":"D Wu","year":"2011","unstructured":"Wu D, Li X, Yang Y, Zheng Y, Wang C, Deng L, Liu L, Li C, Shang Y, Zhao C, Yu S, Shen X (2011) Superantigen gene profiles and presence of exfoliative toxin genes in community-acquired meticillin-resistant Staphylococcus aureus isolated from Chinese children. J Med Microbiol 60:35\u201345. https:\/\/doi.org\/10.1099\/jmm.0.023465-0","journal-title":"J Med Microbiol"},{"key":"384_CR14","doi-asserted-by":"publisher","first-page":"5631","DOI":"10.1128\/AAC.05251-11","volume":"55","author":"K Seidl","year":"2011","unstructured":"Seidl K, Chen L, Bayer AS, Hady WA, Kreiswirth BN, Xiong YQ (2011) Relationship of agr expression and function with virulence and vancomycin treatment outcomes in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 55:5631\u20135639. https:\/\/doi.org\/10.1128\/AAC.05251-11","journal-title":"Antimicrob Agents Chemother"},{"key":"384_CR15","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1007\/s10156-010-0086-0","volume":"17","author":"Y Takesue","year":"2011","unstructured":"Takesue Y, Nakajima K, Takahashi Y, Ichiki K, Wada Y, Tsuchida T, Ishihara M, Uchino M, Ikeuchi H (2011) Clinical characteristics of vancomycin minimum inhibitory concentration of 2 \u03bcg\/ml methicillin-resistant Staphylococcus aureus strains isolated from patients with bacteremia. J Inf Chemot 17:52\u201357. https:\/\/doi.org\/10.1007\/s10156-010-0086-0","journal-title":"J Inf Chemot"},{"key":"384_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/j.diagmicrobio.2011.06.010","volume":"71","author":"H Chen","year":"2011","unstructured":"Chen H, Liu Y, Sun W, Chen M, Wang H (2011) The incidence of heterogeneous vancomycin-intermediate Staphylococcus aureus correlated with increase of vancomycin MIC. Diagn Microbiol Infect Dis 71:301\u2013303. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2011.06.010","journal-title":"Diagn Microbiol Infect Dis"},{"key":"384_CR17","doi-asserted-by":"publisher","first-page":"4203","DOI":"10.1128\/JCM.01152-11","volume":"49","author":"SS Richter","year":"2011","unstructured":"Richter SS, Satola SW, Crispell EK, Heilmann KP, Dohrn CL, Riahi F, Costello AJ, Diekema DJ, Doern GV (2011) Detection of Staphylococcus aureus isolates with heterogeneous intermediate-level resistance to vancomycin in the United States. J Clin Microbiol 49:4203\u20134207. https:\/\/doi.org\/10.1128\/JCM.01152-11","journal-title":"J Clin Microbiol"},{"key":"384_CR18","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1128\/AAC.00380-13","volume":"57","author":"AM Casapao","year":"2013","unstructured":"Casapao AM, Leonard SN, Davis SL, Lodise TP, Patel N, Goff DA, LaPlante KL, Potoski BA, Rybak MJ (2013) Clinical outcomes in patients with heterogeneous vancomycin-intermediate Staphylococcus aureus bloodstream infection. Antimicrob Agents Chemother 57:4252\u20134259. https:\/\/doi.org\/10.1128\/AAC.00380-13","journal-title":"Antimicrob Agents Chemother"},{"key":"384_CR19","doi-asserted-by":"publisher","first-page":"399","DOI":"10.3343\/alm.2015.35.4.399","volume":"35","author":"MJ Park","year":"2015","unstructured":"Park MJ, Kim HS, Kim HS, Kim JS, Song W, Kim MY, Lee YK, Kang HJ (2015) Accessory gene regulator polymorphism and vancomycin minimum inhibitory concentration in methicillin-resistant Staphylococcus aureus. Ann Lab Med 35:399\u2013403. https:\/\/doi.org\/10.3343\/alm.2015.35.4.399","journal-title":"Ann Lab Med"},{"key":"384_CR20","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2016\/8163456","volume":"2016","author":"A Cechinel","year":"2016","unstructured":"Cechinel A, Machado DP, Turra E et al (2016) Association between accessory gene regulator polymorphism and mortality among critically ill patients receiving vancomycin for nosocomial MRSA bacteremia: a cohort study. Canad J Inf Dis Med Microb 2016:1\u20136. https:\/\/doi.org\/10.1155\/2016\/8163456","journal-title":"Canad J Inf Dis Med Microb"},{"key":"384_CR21","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.ijid.2019.11.032","volume":"91","author":"SM Abdulgader","year":"2020","unstructured":"Abdulgader SM, van Rijswijk A, Whitelaw A, Newton-Foot M (2020) The association between pathogen factors and clinical outcomes in patients with Staphylococcus aureus bacteremia in a tertiary hospital, Cape Town. Int J Infect Dis 91:111\u2013118. https:\/\/doi.org\/10.1016\/j.ijid.2019.11.032","journal-title":"Int J Infect Dis"},{"key":"384_CR22","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1097\/PDM.0b013e318208fc47","volume":"20","author":"JT de Sanctis","year":"2011","unstructured":"de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD (2011) Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia? Diagn Mol Pathol 20:184\u2013188. https:\/\/doi.org\/10.1097\/PDM.0b013e318208fc47","journal-title":"Diagn Mol Pathol"},{"key":"384_CR23","doi-asserted-by":"publisher","first-page":"e0118791","DOI":"10.1371\/journal.pone.0118791","volume":"10","author":"V C\u00e1zares-Dom\u00ednguez","year":"2015","unstructured":"C\u00e1zares-Dom\u00ednguez V, Cruz-C\u00f3rdova A, Ochoa SA, Escalona G, Arellano-Galindo J, Rodr\u00edguez-Leviz A, Hern\u00e1ndez-Castro R, L\u00f3pez-Villegas EO, Xicohtencatl-Cortes J (2015) Vancomycin tolerant, methicillin-resistant Staphylococcus aureus reveals the effects of vancomycin on cell wall thickening. PLoS One 10:e0118791. https:\/\/doi.org\/10.1371\/journal.pone.0118791","journal-title":"PLoS One"},{"key":"384_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12866-019-1465-z","volume":"19","author":"X Yang","year":"2019","unstructured":"Yang X, Dong F, Qian S, Wang L, Liu Y, Yao K, Song W, Zhen J, Zhou W, Xu H, Zheng H (2019) Accessory gene regulator (agr) dysfunction was unusual in Staphylococcus aureus isolated from Chinese children. BMC Microb 19:1\u201312. https:\/\/doi.org\/10.1186\/s12866-019-1465-z","journal-title":"BMC Microb"},{"key":"384_CR25","doi-asserted-by":"publisher","first-page":"1558","DOI":"10.1086\/598607","volume":"199","author":"G Sakoulas","year":"2009","unstructured":"Sakoulas G, Moise PA, Rybak MJ (2009) Accessory gene regulator dysfunction: an advantage for Staphylococcus aureus in health-care settings? J Inf Dis 199:1558\u20131559. https:\/\/doi.org\/10.1086\/598607","journal-title":"J Inf Dis"},{"key":"384_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1093\/cid\/cir473","volume":"53","author":"DR Cameron","year":"2011","unstructured":"Cameron DR, Howden BP, Peleg AY (2011) The interface between antibiotic resistance and virulence in Staphylococcus aureus and its impact upon clinical outcomes. Clin Infect Dis 53:576\u2013582. https:\/\/doi.org\/10.1093\/cid\/cir473","journal-title":"Clin Infect Dis"},{"key":"384_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2334-11-287","volume":"11","author":"Y Harigaya","year":"2011","unstructured":"Harigaya Y, Ngo D, Lesse AJ, Huang V, Tsuji BT (2011) Characterization of heterogeneous vancomycin-intermediate resistance, MIC and accessory gene regulator (agr) dysfunction among clinical bloodstream isolates of Staphyloccocus aureus. BMC Inf Dis 11:1\u20137. https:\/\/doi.org\/10.1186\/1471-2334-11-287","journal-title":"BMC Inf Dis"},{"key":"384_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/phar.1577\/abstract","volume":"35","author":"DM Gomes","year":"2015","unstructured":"Gomes DM, Ward KE (2015) Clinical implications of vancomycin heteroresistant and intermediately susceptible Staphylococcus aureus. Pharmacotherapy 35:424\u2013432. https:\/\/doi.org\/10.1002\/phar.1577\/abstract","journal-title":"Pharmacotherapy"},{"issue":"6","key":"384_CR29","doi-asserted-by":"publisher","first-page":"e01425","DOI":"10.1128\/genomeA.01425-16","volume":"4","author":"YD Bakthavatchalam","year":"2016","unstructured":"Bakthavatchalam YD, Veeraraghavan B, Peter JV, Rajinikanth J, Inbanathan FY, Devanga Ragupathi NK, Rajamani Sekar SK (2016) Novel observations in 11 heteroresistant vancomycin-intermediate methicillin-resistant Staphylococcus aureus strains from South India. Genome Announc 4(6):e01425\u2013e01416. https:\/\/doi.org\/10.1128\/genomeA.01425-16","journal-title":"Genome Announc"},{"issue":"12","key":"384_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227009","volume":"14","author":"YD Bakthavatchalam","year":"2019","unstructured":"Bakthavatchalam YD, Babu P, Munusamy E, Dwarakanathan HT, Rupali P, Zervos M, John Victor P, Veeraraghavan B (2019) Genomic insights on heterogeneous resistance to vancomycin and teicoplanin in methicillin-resistant Staphylococcus aureus: a first report from South India. PLoS One 14(12):e0227009. https:\/\/doi.org\/10.1371\/journal.pone.0227009","journal-title":"PLoS One"},{"key":"384_CR31","doi-asserted-by":"publisher","first-page":"114854","DOI":"10.1016\/j.diagmicrobio.2019.06.006","volume":"95","author":"ACO Silveira","year":"2019","unstructured":"Silveira ACO, Caier\u00e3o J, Silva CI, Anzai EK, McCulloch JA, d'Azevedo PA, Sincero TCM (2019) Impact of mutations in hVISA isolates on decreased susceptibility to vancomycin, through population analyses profile - area under curve (PAP-AUC). Diagn Micr Infec Dis 95:114854. https:\/\/doi.org\/10.1016\/j.diagmicrobio.2019.06.006","journal-title":"Diagn Micr Infec Dis"},{"issue":"2","key":"384_CR32","first-page":"269","volume":"90","author":"WA Mcguinness","year":"2017","unstructured":"Mcguinness WA, Malachowa N, Deleo FR (2017) Vancomycin resistance in Staphylococcus aureus. Yale J Biol Med 90(2):269\u2013281 PMC5482303","journal-title":"Yale J Biol Med"}],"container-title":["Brazilian Journal of Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00384-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42770-020-00384-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42770-020-00384-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,19]],"date-time":"2021-10-19T06:01:06Z","timestamp":1634623266000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42770-020-00384-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,19]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["384"],"URL":"https:\/\/doi.org\/10.1007\/s42770-020-00384-0","relation":{},"ISSN":["1517-8382","1678-4405"],"issn-type":[{"value":"1517-8382","type":"print"},{"value":"1678-4405","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,19]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"All authors declare no conflicts of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interests"}},{"value":"The study was approved by Federal University of Health Sciences of Porto Alegre (UFCSPA) Institutional Ethics under number 2.770.338.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}}]}}